💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Repligen Corporation (RGEN)
« Back to company indexRGEN Chatter Timeline
Stock Ticker for RGEN
Most Active Tweeters for RGEN
| User | Tweets |
|---|---|
| @AitkenResearch | 2 |
| @formwhisperscom | 1 |
| @fintel_io | 1 |
| @MarcJacksonLA | 1 |
| @FlashAlert_me | 1 |
Recent Tweets for RGEN
 |
@MarcJacksonLA $RGEN Repligen: A Picks-And-Shovels Play On Biological Therapy Growth https://t.co/1QB5wuggkM April 13th 2021, 2:04pm |
 |
@CalebFranzen $RGEN - UPDATE: Achieves a breakout this morning with a +1% gap higher. Important to confirm that price holds above… https://t.co/RdQmuEM1em April 13th 2021, 1:04pm |
 |
@mediasentiment $RGEN new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 319 April 12th 2021, 3:04pm |
 |
@TipRanks Repligen: A Picks-And-Shovels Play On Biological Therapy Growth https://t.co/KyBuS2Xg7O $RGEN April 12th 2021, 2:04pm |
 |
@stockhoot $RGEN HC Wainwright & Co. Reiterates to Buy : PT $225.00 https://t.co/igP7X9HiFr April 12th 2021, 10:04am |
 |
@AitkenResearch Expect2Win nutrition/stocks. $RGEN $LLY [email protected]? [email protected]? Regeneron/Roche's antibody cocktail reduces… https://t.co/BMS1W4GEnX April 12th 2021, 9:04am |
 |
@msmith888888 $RGEN #buysignal on the weekly chart. https://t.co/tUrH1fV3PB April 10th 2021, 12:04am |
|
@AitkenResearch @KDKA Anyone catching the Covid virus shld imd contact your physican to get the antibody from $LLY $RGEN asap after… https://t.co/4NER1bbBjt April 9th 2021, 3:04pm |
 |
@formwhisperscom #FWSells $RGEN Bylund James, SVP, Global Operations & IT of REPLIGEN CORP sold 360 shares on 2021-04-06. https://t.co/hmEPTyBvl6 April 9th 2021, 3:04am |
 |
@InsiderAlerts4U $RGEN: New Insider Filing on REPLIGEN CORP's SVP, Global Operations & IT JAMES BYLUND: https://t.co/fpM6IZfLfd April 9th 2021, 12:04am |
 |
@StockTexts $RGEN Repligen Corporation SEC Filing: Form 4 https://t.co/5TFTQOz7AO April 9th 2021, 12:04am |
 |
@InsiderForms $RGEN Insider Bylund James has Sold 360 Shares. Title :SVP Global Operations; IT Total Cost: $73,530.0 Buy/Sell :… https://t.co/G16KO8pOqw April 9th 2021, 12:04am |
 |
@insiderbuyings $RGEN new insider selling: 360 shares. https://t.co/P3MSeFbkls April 9th 2021, 12:04am |
 |
@FlashAlert_me $RGEN [15s. delayed] filed SEC form 4: SVP, Global Operations & IT Bylund James: Disposed 360 of Common Stock at p… https://t.co/hL4HoWOnBS April 8th 2021, 11:04pm |
 |
@fintel_io Insider James Bylund reports selling 360 shares of $RGEN for a total cost of $73,530.00 https://t.co/K7pQ7MblFH April 8th 2021, 11:04pm |
|
@CalebFranzen $RGEN - Classic stair-step behavior in a clear trend. Note how the 200 day EMA (blue) has been a great buying oppor… https://t.co/69suOelitm April 4th 2021, 6:04pm |
 |
@TradeWithAlerts Large Print $RGEN Size: 131900 Price: 195.44 Time: 1726 Amount: $25,778,536.00 April 1st 2021, 9:04pm |
|
@mediasentiment $RGEN new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 568 March 31st 2021, 11:03pm |
|
@mediasentiment $RGEN new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 567 March 31st 2021, 11:03pm |
 |
@ChartMill $RGEN shows a strong growth in Revenue. Over the last 5 years it has been growing by 34.39% yearly.… https://t.co/Tw02xtcVgl March 31st 2021, 11:03pm |
|
@TradeWithAlerts Large Print $RGEN Size: 236913 Price: 194.41 Time: 1600 Amount: $46,058,256.33 March 31st 2021, 8:03pm |
 |
@theCaptainBull $RGEN - We had a small upward bounce as predicted but it went down afterward. Should have gotten minor profit if en… https://t.co/99oAwme2Ss March 31st 2021, 1:03pm |
 |
@Invest4decades Chose $RGEN over $ADYYF because gene editing is a massive market that will require many attempts to bring drugs to… https://t.co/Hp6r0FO0qQ March 31st 2021, 2:03am |
 |
@MA32861980 Repligen $RGEN Leerink Partners analyst Puneet Souda maintained a Buy rating on Repligen (NASDAQ:RGEN) Corp on Mon… https://t.co/D5BV77tIBz March 28th 2021, 1:03pm |
|
@MA32861980 I like Repligen. $RGEN 3 Disruptive Stocks to Buy and Hold for the Next Decade https://t.co/vZd1xKw046 March 28th 2021, 12:03pm |
|
@MA32861980 I like $RGEN. https://t.co/fFB3ZmsRNz March 28th 2021, 12:03pm |
 |
@trademarktrader ROBOCOLUMN new trademark application by Repligen Corporation https://t.co/32yuuyPcMK #ROBOCOLUMN $RGEN $RPGN https://t.co/Qv9GZUI54l March 27th 2021, 2:03am |
|
@MarcJacksonLA $RGEN Leerink Maintains Buy Rating On Repligen, $560 PT https://t.co/CkYFpHXWIN March 25th 2021, 5:03pm |
 |
@DisliasIoannis $RGEN Repligen’ earnings estimates have been revised 15.1% upward for 2021 and 9.8% for 2022 over the past 60 days.… https://t.co/EeMg5BXNmP March 22nd 2021, 8:03pm |
 |
@tick_signals $RGEN signal was generated on Mar 17 and hit the +4.75% target in 5 days. if you missed out, don't worry we have p… https://t.co/sq3JFLmAHX March 22nd 2021, 7:03pm |
 |
@MA32861980 I'm bullish on $RGEN and $VEEV. "A low-risk way to play the biotech boom is to buy companies that are key supplier… https://t.co/nrwsJ6vUHv March 20th 2021, 12:03pm |
 |
@newsfilterio $275,632.00 of shares sold by Gebski Christine (See Remarks), reported in a new form 4 filed with the SEC $RGEN https://t.co/eyjMRihwd3 March 20th 2021, 6:03am |
 |
@SentiQuanti Automatic Charting : $RGEN https://t.co/Y8BxbclNVu March 19th 2021, 8:03pm |
|
@MarcJacksonLA $RGEN Stocks With Rising Relative Strength: Repligen https://t.co/Mkq2Rc6hED via @IBDinvestors March 19th 2021, 3:03pm |
|
@InsiderAlerts4U $RGEN: New Insider Filing on REPLIGEN CORP's Insider CHRISTINE GEBSKI: https://t.co/fiw0XPXVbt March 19th 2021, 8:03am |
|
@StockTexts $RGEN Repligen Corporation SEC Filing: Form 4 https://t.co/5j5UKb4Eoj March 19th 2021, 3:03am |
|
@insiderbuyings $RGEN new insider selling: 1400 shares. https://t.co/P3MSeFbkls March 19th 2021, 2:03am |
|
@StockTexts $RGEN Repligen Corporation SEC Filing: Form 4 https://t.co/5j5UKaN3wL March 19th 2021, 2:03am |
|
@fintel_io Insider Christine Gebski reports selling 1,400 shares of $RGEN for a total cost of $275,632.00 https://t.co/UEhMkOn0qI March 19th 2021, 1:03am |
|
@FlashAlert_me $RGEN [15s. delayed] filed SEC form 4: See Remarks Gebski Christine: Disposed 1,400 of Common Stock at price $196.… https://t.co/6aHX6ccCDn March 19th 2021, 1:03am |
|
@formwhisperscom #FWSells $RGEN Gebski Christine, of REPLIGEN CORP sold 1,400 shares on 2021-03-16. https://t.co/hmEPTyBvl6 March 19th 2021, 1:03am |
|
@newsfilterio Repligen to Present at KeyBanc Life Science and MedTech Investor Forum $RGEN https://t.co/h8zeCsXcWm March 18th 2021, 6:03am |
|
@MarcJacksonLA $RGEN Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum https://t.co/Gd7Bb5YQ7j March 17th 2021, 3:03pm |
|
@FlashAlert_me $RGEN [15s. delayed]: Issued Press Release on March 17, 07:30:00: Repligen Corporation to Present at KeyBanc Life S… https://t.co/pi8CjwVMaG March 17th 2021, 11:03am |
 |
@stock_titan $RGEN Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum https://t.co/wZYtqxwg6H March 17th 2021, 11:03am |
|
@InsiderAlerts4U $RGEN: New Insider Filing on REPLIGEN CORP's Director THOMAS F JR RYAN: https://t.co/utZdePyWjC March 17th 2021, 4:03am |
|
@StockTexts $RGEN Repligen Corporation SEC Filing: Form 4 https://t.co/9lruRd3qO5 March 17th 2021, 1:03am |
|
@FlashAlert_me $RGEN [15s. delayed] filed SEC form 4: Director RYAN THOMAS F JR: Gifted 170 of Common Stock at price $0 on 2021-0… https://t.co/59DygaDBf5 March 17th 2021, 1:03am |
 |
@JBMGStockTrades $RGEN short if we close weak today. Retest of $180 https://t.co/BAaKEVTbmM March 16th 2021, 5:03pm |
 |
@aistockfinder $RGEN https://t.co/YTvdLrFS0t Repligen Corp. Our model is predicting the market value of this company has an undete… https://t.co/qnJnre7vMl March 15th 2021, 11:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
